Lipopolysaccharide Activates Toll-Like Receptor 4 and Prevents Cardiac Fibroblast-to-Myofibroblast Differentiation.

导出 LinkOut

翻译打印收藏纠错

第一作者： Samir,Bolívar

第一单位： Department of Pharmacological and Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.

作者： Samir,Bolívar ^[1] ; Roxana,Santana ^[2] ; Pedro,Ayala ^[3] ; Rodolfo,Landaeta ^[1] ; Pía,Boza ^[4] ; Claudio,Humeres ^[3] ; Raúl,Vivar ^[1] ; Claudia,Muñoz ^[3] ; Viviana,Pardo ^[1] ; Samuel,Fernandez ^[3] ; Renatto,Anfossi ^[1] ; Guillermo,Diaz-Araya ^[3]

作者单位： Department of Pharmacological and Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile. ^[1] Faculty of Chemistry and Pharmacy, Atlantic University, Barranquilla, Colombia. ^[2] Advanced Center for Chronic Diseases (ACCDiS), Faculty of Chemical and Pharmaceutical Sciences and Faculty of Medicine, University of Chile, 8380492, Santiago, Chile. ^[3] Center of Medical Investigations, Catholic University of Chile, Santiago, Chile. ^[4] Advanced Center for Chronic Diseases (ACCDiS), Faculty of Chemical and Pharmaceutical Sciences and Faculty of Medicine, University of Chile, 8380492, Santiago, Chile. gadiaz@ciq.uchile.cl. ^[5] Department of Pharmacological and Toxicological Chemistry, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile. gadiaz@ciq.uchile.cl. ^[6]

关键词 Cardiac fibroblast Lipopolysaccharide TLR4 α-SMA